Why Immunovant Stock Dropped Today
1 minuto de lectura
What happened?Shares of clinical-stage biopharmaceutical company Immunovant (NASDAQ: IMVT) plunged by 27.2% on Tuesday following the company’s release of its financial results for the third quarter of its fiscal year 2021 that ended on Dec. 31.Read MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
